Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Exercise and brain stimulation for improving memory in patients with vascular cognitive impairment

Official title: Exercise as a Primer for Excitatory Stimulation Study in Vascular Cognitive Impairment No Dementia (EXPRESS-V)

Run by Sunnybrook Health Sciences Centre · NCT05079464 · Data updated 2026-11-12

This study is testing whether combining exercise with brain stimulation can help improve memory in people with vascular cognitive impairment who have finished cardiac rehab.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment64 (estimated)
SponsorSunnybrook Health Sciences Centre
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedNovember 22, 2021
Main results expectedSeptember 2026
Study endsDecember 2026
Registry record updatedApril 13, 2026
Trial IDNCT05079464 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 50 and older with vascular risk factors and mild cognitive impairment.

Probably not a fit

Patients with a history of stroke or significant neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of exercise combined with transcranial direct current stimulation (tDCS) on memory performance in individuals with vascular cognitive impairment who have completed cardiac rehabilitation. Participants will be randomized into four groups: one receiving exercise followed by active tDCS, another receiving treatment as usual with active tDCS, a third group receiving exercise followed by sham tDCS, and a final group receiving treatment as usual with sham tDCS. The study aims to determine if exercise can prime the brain for better stimulation effects, with assessments of cognition, behavior, neuroimaging, and blood biomarkers. The goal is to find effective interventions for improving cognitive function in at-risk populations.

Why it matters

Potential benefit: If successful, this approach could enhance memory performance and cognitive function in patients at risk of cognitive decline due to vascular issues.

How similar studies have gone: Other studies have shown promise in using tDCS for cognitive enhancement, but this specific combination with exercise is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥50 years of age; females must be post-menopausal
* Presence of cerebrovascular and/or cardiovascular risk factors or coronary artery disease
* Montreal Cognitive Assessment (MoCA) \<27
* Sufficiently proficient in English
* Must be able to exercise at a moderate intensity level
* Presence of modest deficits (1 standard deviation below population norm) in one of the following domains: executive function, verbal memory, working memory, or visuospatial memory

Exclusion Criteria:

* History of stroke
* Change in psychotropics within the last 4 weeks
* Current benzodiazepine use due
* Metal implants that would preclude safe use of tDCS or neuroimaging
* Significant neurological or psychiatric conditions (current major depressive disorder, bipolar disorder, schizophrenia)
* MoCA \<18 and/or clinical diagnosis of dementia
* Any medical contraindications to exercise

Where it's running

  • Sunnybrook Health Sciences Centre
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.